ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, supplying promising progress across various clinical and industrial purposes. With its structural similarity to Obviously derived human serum albumin, OsrHSA presents a safer, far more reliable option for therapeutic use, significan